adakveo
novartis europharm limited - crizanlizumab - anemi, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.
jakavi
novartis europharm limited - ruxolitinib (som fosfat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastiske midler - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi er indisert for behandling av voksne pasienter med polycythaemia vera som er resistente mot eller intolerante av hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.
zykadia
novartis europharm limited - ceritinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - zykadia er indisert for behandling av voksne pasienter med anaplastisk lymfomkinase (alk) positiv avansert ikke-småcellet lungekreft (nsclc) som tidligere ble behandlet med crizotinib.
benferol 400 iu
consilient health limited - kolekalsiferol - kapsel, myk - 400 iu
benferol 800 iu
consilient health limited - kolekalsiferol - kapsel, myk - 800 iu
benferol 5600 iu
consilient health limited - kolekalsiferol - kapsel, myk - 5600 iu
benferol 25000 iu
consilient health limited - kolekalsiferol - kapsel, myk - 25000 iu
benferol 50000 iu
consilient health limited - kolekalsiferol - kapsel, myk - 50000 iu
haldol 1 mg
essential pharma limited - haloperidol - tablett - 1 mg
tropikamid minims 5 mg/ ml
bausch + lomb ireland limited - tropikamid - Øyedråper, oppløsning - 5 mg/ ml